Niew Jeffrey

CEO Niew Jeffrey executes matched buy-sell of 142,857 shares; stock near 52-week highs after sharp recent rally.

Niew Jeffrey, President and CEO of Knowles Corp, executed a same-day purchase and sale of identical share quantities—buying at a lower price and immediately selling at a significantly higher price on May 5th. This is fundamentally a financial transaction rather than a shift in conviction about the company. The stock is currently trading near its 52-week high and has rallied substantially over the past three months, yet the CEO's prior sales history shows mixed timing results: while recent sales have been followed by further stock appreciation over the following 90 days, indicating poor exit timing, the shorter 30-day windows show much more modest moves. The company remains profitable with steady revenue growth, though it trades at a notably elevated valuation multiple. This matched buy-sell structure—locking in a gain between the two prices in a single day—is a mechanical transaction that does not reflect the same conviction signal as a straight purchase or sale would, and investors should view it as such rather than as a bullish or bearish statement about Knowles' prospects.

KN CEO Niew Jeffrey sold 75,000 shares (75.0K) for $1,987,500.00 ($2.0M) in 3 tranches at $26.00–$27.00 on 2026-02-06, near 52-week high of $26.98.

KN CEO Niew Jeffrey executed 3 separate sales totaling 75,000 (75.0K shares) for $1,987,500.00 ($2.0M) at a blended average price of $26.50, reducing his holdings from 814,370 shares (814.4K shares) to 739,370 shares (739.4K shares), a -9.2% reduction. The transactions occurred at prices ($26.00, $26.50, $27.00) very close to the current price of $26.98, which marks the 52-week high (+0.0% from 52-week high), and follow a recent sales pattern at the company: five prior KN trades within the past 3 months (Dec 4, Dec 10, Jan 15, Jan 15, Feb 3), with measurable 30-day outcomes on two of those showing -6.6% and -3.6% returns. The company is operating under headwind conditions (annual revenue growth -21.8%, full-year net income was negative, P/E 55.06), which adds material context to executive liquidity activity at elevated price levels. This sequence of repeated sales near the 52-week high warrants attention as a pattern of executive liquidation during a period of revenue contraction and profitability stress.

CEO Niew Jeffrey sold 25,000 shares of KN at $25.50 on 2026-02-03; stock near 52-week highs despite -21.8% annual revenue decline.

Niew Jeffrey, President & CEO, sold 25,000 shares (814.4K shares remaining post-transaction) near the 52-week high of $25.14, with the sale price of $25.50 representing near-peak valuation. This sale occurs against a backdrop of significant operational headwinds: annual revenue growth is -21.8% and the company was unprofitable over its most recent full fiscal year, yet the stock trades at a P/E of 50.18. At the same-ticker level, Niew's prior four measurable sales (dating back to November 2025) show mixed outcomes: two were followed by 30-day declines (-3.6% and -6.6%), though his longer-term 90-day pattern at KN shows only 1 prior completed sale with a measurable 90-day outcome (+2.9% return). His cross-ticker track record shows 7 prior sells with a 90d well-timed rate of 33.33%, suggesting modest timing accuracy historically. The concentration of sales activity at this ticker (5 trades in three months) warrants attention alongside the fundamental deterioration.

KN CEO Niew sells 50,000 shares in 2 tranches for $1,237,500.00; stock up 8.7% in 30d but revenue down 21.8% YoY

President & CEO Niew Jeffrey executed 2 separate sales totaling 50,000 shares for $1,237,500.00 at an average price of $24.75, reducing his holdings by 5.6% to 839,370 shares. The sales occurred after a strong 30-day rally of 8.7%, yet Knowles Corp faces significant operational headwinds: annual revenue declined 21.8%, the company posted negative full-year net income, and the stock trades at a 49.06 P/E despite $152.9M in latest-quarter revenue. His prior sales at this ticker show a mixed pattern, with only 1 of 5 prior trades well-timed at the 90-day mark, though his broader cross-ticker track record shows 100% well-timed sales. The timing of this sale after a near-term rally coincides with deteriorating fundamentals, though the absence of a 10b5-1 plan disclosure in this filing precludes any assertion about whether the transaction was discretionary.

CEO Jeffrey Niew sold 25,000 shares (25.0K) of KN at $24.00 on 2025-12-10 for $600,000.00 (600.0K); stock now at $22.88.

Jeffrey Niew, President & CEO, sold 25,000 shares at $24.00 on 2025-12-10, a 2.7% reduction in holdings that generated $600,000.00. The sale occurred near the 52-week high of $24.41 (only 1.7% below), yet the stock has since declined to $22.88, down 6.3% from the high. His prior trades at KN show a mixed pattern: 1 of 1 measurable 90-day outcomes resulted in post-sale declines (well-timed on 2024-11-06 with a -2.4% 90d return), while three recent sells (2025-10-31, 2025-11-03, 2025-12-04) have shown or are showing negative 30-day returns. The company faces headwinds: annual revenue contracted 21.8% year-over-year and full-year net income was negative despite positive recent quarterly earnings of $17.4M on $152.9M revenue. The elevated P/E of 46.69 on a valuation basis troubled by prior-year losses contrasts sharply with the CEO's execution pattern at this ticker, where his sales have aligned with subsequent price weakness.

CEO Jeffrey Niew sold 25.0K KN shares at $23.50 on 2025-12-04; holds 914.4K shares post-trade.

Jeffrey Niew (President & CEO) sold 25,000 shares valued at $587,500.00, reducing his holdings by 2.7% to 914,370 shares. The sale occurred near the 52-week high ($24.41), with current price $23.42 only 0.3% below the transaction price. Across his full cross-ticker open-market history, Niew's 3 prior sells achieved a 100.00% well-timed rate at the 90-day mark, though his average 90d return of -2.4% signals modest predictive value; same-ticker at KN, only 1 of 1 measurable 90d outcomes was well-timed (the 2024-11-06 sale fell -2.4% over 90 days), while his two most recent KN sales remain unmeasured beyond 30 days. The underlying company faces structural headwinds: annual revenue contracted -21.8% year-over-year, the company was unprofitable over its most recent full fiscal year, and the P/E ratio of 47.80 reflects elevated valuation relative to earnings. The sale pattern—three KN dispositions in 34 days (2025-10-31, 2025-11-03, 2025-12-04)—warrants monitoring against forward guidance and quarterly results.

Knowles CEO Jeffrey Niew sold 136,656 shares for $3.2M at average $23.67, retaining 939.4K shares (12.7% reduction)

Jeffrey Niew, President & CEO of Knowles Corp, executed 2 separate sales totaling 136,656 shares for $3,234,433.05 at an average price of $23.67 on October 31 and November 3, 2025. The stock currently trades at $22.68, down 5.7% over 30 days and down 7.1% from its 52-week high of $24.41, placing the sale prices above near-term support. Notably, Knowles reported annual revenue decline of -21.8% and full-year net income was negative despite recent quarterly revenue of $152.9M and net income of $17.4M, suggesting operational stress in the business. Niew's prior sell at this ticker in November 2024 was well-timed (the stock subsequently declined), though the cross-ticker track record shows 1 prior sell with an average 90-day return of -2.4%, indicating a modest historical pattern of selling before weakness.

CEO Jeffrey Niew sells 157,699 shares of Knowles Corp at $18.98 for $2,993,127.02; retains 820,698 shares post-sale

Jeffrey Niew, President & CEO, executed a sale of 157,699 shares at $18.98 on 2024-11-06, reducing his holdings by 16.1% from 978,397 shares to 820,698 shares. The transaction occurred near the 52-week high ($19.17 current price is -1.4% from the $19.44 peak), and the stock has appreciated 10.8% over 30 days and 12.3% over 90 days, indicating strong recent momentum. Against this backdrop of improving price action, the CEO's sale of a meaningful proportion of his position warrants attention to whether it reflects liquidity needs, portfolio rebalancing, or a shift in conviction about near-term prospects; the company's fundamentals show annual revenue decline of -7.5% and a P/E of 23.96, suggesting the valuation may be pricing in recovery that operational results have not yet confirmed.